For people with non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH), semaglutide often reduces liver fat content and improves liver enzyme levels over several months
However, oral and nasal administration have benefits for reducing brain inflammation, accelerated neuron repair, and fighting off allergy and mold toxicity symptoms
This creates symptoms of aging that include an increase in body fat, loss of libido, muscle mass and bone density, wrinkled skin, thinning hair, and sleep issues, among others
No, retatrutide remains investigational as of early 2026
That opposition matters because it came from the people whose job is exclusively to evaluate risk, not from outside critics
Let both the peptide vial and bacteriostatic water vial reach room temperature